Sign in / Join Now
ETFs & Funds
Biotech holds include $
, $ STEM, $
. Questioning ARQL, NLNK, but holding for now...
Add a reply...
Latest StockTalks »
people get ARQL breaking news and analysis by email alert.
Get email alerts on ARQL »
Get latest price
From other sites
ArQule (ARQL) Catches Eye: Stock Moves 7.2% Higher
at Zacks.com (Fri, 8:00AM)
Data On Proprietary BTK Inhibitor, ARQ 531, Demonstrating Inhibition Of Wild Type And C481S Mutant BTK And Superiority To Ibrutinib In TCL1 Mouse Model Presented At The American Society Of Hematology Annual Meeting
at TheStreet (Dec 4, 2016)
Preclinical Data On Proprietary AKT Inhibitor, ARQ 092, Demonstrating Effectiveness In The Treatment Of Sickle Cell Disease Presented At The American Society Of Hematology Annual Meeting
at TheStreet (Dec 3, 2016)
ArQule Reports Third Quarter 2016 Financial Results
at TheStreet (Nov 7, 2016)
Advancements In ArQule's Proprietary Pipeline To Be Highlighted At The 2016 American Society Of Hematology Annual Meeting
at TheStreet (Nov 3, 2016)